CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETH

The Defense Logistics Agency awarded a delivery order under basic contract SPE2DX-25-D-9822 to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) on July 16, 2026, for the procurement of 4 units of Ciprofloxacin Hydrochloride and Dexamethasone, identified by NSN 6505015323362, at a total price of $178.60. The order is classified as a small business award with affirmative certifications for both Small Disadvantaged Business and Women-Owned Small Business status, indicating socioeconomic preferential treatment under FAR provisions. Delivery is required FOB Destination to Electric Boat Corporation in North Stonington, Connecticut, with inspection and acceptance performed by the Government at the delivery point. Shipping must be conducted via the fastest traceable means, excluding parcel post, and all packages must be marked with the basic contract number SPE2DX-25-D-9822 and delivery order number SPE2D2-26-F-3034, along with manufacturer CAGE codes and part numbers. The award was likely made on a Lowest Price Technically Acceptable basis given the commodity nature of the pharmaceutical item and minimal cost. Payment is administered by the Defense Finance and Accounting Service in Columbus, Ohio, using the specified AAC/TAS/ACRN code, with no electronic invoicing method explicitly defined. The contracting officer is Lisa Quinn, and administrative support is provided by DLA Troop Support in Philadelphia, with Jayne Do as the local administrative contact; no Contracting Officer’s Representative or Technical Representative is named. Packaging, preservation, and labeling standards conform to basic DoD guidance without explicit reference to MIL-STD requirements, and no special contractual clauses, security clearances, options, or performance metrics beyond delivery and acceptance are detailed. The contract is a single, firm-fixed-price delivery with no stated extensions, options, or future order potential.